Inconsistency in Risperidone Long-Acting Injection Steady-State Plasma Levels When Switching From Deltoid to Gluteal Administration

被引：9
|
作者：
Elliott, Ellie S. R. [1 ]
Purvis, Tara L.
Nelson, Leigh Anne
Sommi, Roger W.
机构：
[1] Ctr Behav Med, Kansas City, MO 64108 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 06期
关键词：
Risperidone long-acting injection; pharmacokinetics; deltoid injection; gluteal injection;
D O I：
10.1177/0091270009350622
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：721 / 724
页数：4
相关论文
共 50 条
  • [1] Risperidone Long-Acting Injection: Pharmacokinetics Following Administration in Deltoid Versus Gluteal Muscle in Schizophrenic Patients
    Thyssen, An
    Rusch, Sarah
    Herben, Virginie
    Quiroz, Jorge
    Mannaert, Erik
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1011 - 1021
  • [2] Pharmacokinetic profile of long-acting injectable risperidone at steady-state : comparison with oral administration
    Mannaert, E
    Vermeulen, A
    Remmerie, B
    Bouhours, P
    Levron, JC
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2005, 31 (05): : 609 - 615
  • [3] Patients' acceptance of the deltoid application of risperidone long-acting injection
    Heres, Stephan
    Frobose, Teresa
    Hamann, Johannes
    Leucht, Stefan
    Maino, Katja
    Reichhart, Tatjana
    Stiegler, Michaela
    Kissling, Werner
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (12) : 897 - 901
  • [4] Breakthrough symptoms after switching long-acting injectable paliperidone palmitate from the gluteal to the deltoid site of administration
    Procyshyn, Ric M.
    Banasch, Jan L.
    Barr, Alasdair M.
    Honer, William G.
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2016, 41 (03): : E56 - E57
  • [5] RISPERIDONE LONG-ACTING INJECTABLE (RLAI) ADMINISTRATION IN DELTOID MUSCLE ... REALLY IS AN IMPROVEMENT?
    Arques, S.
    Arnau, F.
    Rubio, T.
    Pino, A.
    Iranzo, C.
    EUROPEAN PSYCHIATRY, 2011, 26
  • [6] Effects of switching to risperidone long-acting injection on cognitive function in schizophrenia
    Suzuki, H.
    Inoue, Y.
    Otomo, M.
    Kawaguchi, Y.
    Gen, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S463 - S463
  • [7] Health resource utilization associated with switching to risperidone long-acting injection
    Young, C. L.
    Taylor, D. M.
    ACTA PSYCHIATRICA SCANDINAVICA, 2006, 114 (01) : 14 - 20
  • [8] A study of the efficacy and safety of switching from oral risperidone to risperidone long-acting injection in older patients with schizophrenia
    Suzuki, Hidenobu
    Inoue, Yuichi
    Gen, Keishi
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (06) : 227 - 234
  • [9] The influence of switching from oral risperidone to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia
    Suzuki, Hidenobu
    Gen, Keishi
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (01) : 23 - 29
  • [10] Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patients
    Li, H. F.
    Gu, N. F.
    Zhou, M.
    Jia, F. J.
    Zhao, Z. H.
    Fan, J. X.
    Wang, G.
    Sun, X. L.
    Li, M.
    Zhang, J. B.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S405 - S406
12345